CORE, Gemspring, Frazier, AEA and Ampersand are doing medical device deals.
The buyer, Francisco Partners, is a San Francisco-based investment firm that partners with technology businesses.
'We have seen some PE investors ‘pause’ activity, with this temporary hiatus creating new opportunities for strategic acquirers who are able to raise financing more efficiently given prior track records and relationships,' says Maxwell Johnston, head of M&A Apex Group.
Generative AI will help PE investors 'spend more time on second-level investment thinking and less on the groundwork,' said Hamilton Lane's Griff Norville.
‘I still believe it's one of the best investing environments that I can think of,’ said the private equity firm’s chairman of Europe.
'Whilst not quite a golden era, we see high levels of software adoption and penetration by pharma for some time to come,' says Simon Cottle of Stanley Capital.
Arbor Investments, Entrepreneurial Equity Partners and Copley Equity Partners are among the firms making deals.
Nuvei took Paya private in a $1.3bn acquisition that closed in February.
ArcLight recently agreed to acquire part of Duke Energy’s commercial distributed energy business for $364m.
Ardian recently announced it's buying a 50% stake in MXT Holdings.